Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Shares in Arcutis Biotherapeutics (NASDAQ: ARQT) soared by almost 30% in trading to 10:30 a.m. ET today. The move comes after ...
Cytokind announces recently published results in the peer-reviewed Multiple Sclerosis and Related Disorders journal, demonstrating that narrowband UVB (NB-UVB) phototherapy's broad anti-inflammatory ...
Psoriasis is a systemic disease affecting the body, not just the skin; awareness and management are crucial for patients.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin conditions such as acne, psoriasis, and vitiligo, today announced that its ...
Objective To investigate the association between peripheral disease activity and pre-eclampsia, gestational hypertension, preterm birth and fetal growth in women with psoriatic arthritis (PsA).Methods ...
Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across strict measures of peripheral ...
Childhood emotional trauma significantly elevates psoriasis risk by disrupting immune responses, new research reveals. Early ...
Psoriatic arthritis disease activity levels appear to increase on average during perimenopause before decreasing slightly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback